Home | Pharmaceutical Outsourcing - The Journal of Pharmaceutical & Biopharmaceutical Contract Services

Close Ad ☒

Show Ad

Engaging with Regulators for Single-Arm Oncology Research Trials
When well-planned and well-executed, single-arm trials can accelerate access to life-saving therapies that might otherwise never reach desperate cancer patients. read more
Horizon Lines: A Quarterly Review of NDAs – October- December 2025
This quarterly review of New Drug Applications contains data for applications approved for the first time during the last quarter of 2025, which includes New Molecular Entities (NMEs) and new biologics. A total of 40 applications were approved by the FDA during these three months. read more
An Interview With Kim Boericke
Veristat’s new CEO, Kim McLean Boericke, is one step closer to changing the tide in representing the small fraction of companies led by women and is now the only female with the highest job among the top-8 clinical research organizations (CROs). read more
An Interview With Franco Negron
Simtra’s capability to support high-volume injectables and lower-volume modalities provides balanced expertise across the sterile injectables landscape. read more

Clinical Trials - Transforming Drug Development
Transforming Drug Development: Accelerating Clinical Trials through Patient-Centric Innovations and Technological Breakthroughs Watch Now

Sygnature Discovery Establishes DEL Screening Collaboration with X-Chem
Monday, September 14, 2026
Sygnature Discovery has established a formal collaboration with X-Chem to support the delivery of DEL screening within its integrated drug discovery ... read more
Transcenta Licenses Continuous Bioprocessing Technology to WuXi Biologics
Thursday, September 10, 2026
Transcenta Therapeutics and WuXi Biologics have entered a technology licensing and strategic collaboration agreement covering Transcenta’s HiCB ... read more
CordenPharma Invests $94M to Reach 500M Injectable Units Capacity
Thursday, September 10, 2026
CordenPharma plans to invest €80 million, or about $94 million, over multiple years to expand sterile injectable manufacturing at its Caponago site ... read more
Quva Acquires CAPS 503B Sterile Compounding Product Portfolio
Thursday, September 10, 2026
Quva Pharma has acquired a portfolio of sterile compounded medications from Central Admixture Pharmacy Services, or CAPS, after CAPS decided to exit ... read more
Summit Acquires Dallas Research Institute Through Pinnacle Network
Thursday, September 10, 2026
Summit Clinical Research Solutions has acquired Dallas Research Institute through its Pinnacle Clinical Research site network, expanding its clinical-... read more